Antibody Coadministration as a Strategy to Overcome Binding-Site Barrier for ADCs: a Quantitative Investigation. [PDF]
AAPS J, 2020 Singh AP +5 more
europepmc +1 more source
Haplotype-based association mapping of genomic regions associated with Zymoseptoria tritici resistance using 217 diverse wheat genotypes. [PDF]
BMC Plant BiolRadecka-Janusik M +5 more
europepmc +1 more source
Cancer-derived exosomes from HER2-positive cancer cells carry trastuzumab-emtansine into cancer cells leading to growth inhibition and caspase activation. [PDF]
BMC Cancer, 2018 Barok M +5 more
europepmc +1 more source
Antibody-drug conjugates in colorectal cancer: advances in targeted delivery and personalized oncology. [PDF]
Front Bioeng BiotechnolWang H +6 more
europepmc +1 more source
Antibody-drug conjugates targeting HER2 for the treatment of urothelial carcinoma: potential therapies for HER2-positive urothelial carcinoma. [PDF]
Front PharmacolShih CH, Lin YH, Luo HL, Sung WW.
europepmc +1 more source
Loss of meningeal lymphatic endothelial cells results in formation of a newly forming vascular network with scavenging function. [PDF]
DevelopmentUphoff K +5 more
europepmc +1 more source
Nagrobek Łukasza Górnickiego, syna pisarza w katedrze fromborskiej
Archiwa, Biblioteki i Muzea Kościelne, 1966 Jerzy Starnawski
doaj +1 more source
History of trastuzumab: a case study in health technology reassessment and natural disinvestment in Veneto Region. [PDF]
Front PharmacolBecchetti AG +3 more
europepmc +1 more source
The potential for trastuzumab emtansine in human epidermal growth factor receptor 2 positive metastatic breast cancer: latest evidence and ongoing studies. [PDF]
Ther Adv Med Oncol, 2012 Hurvitz SA, Kakkar R.
europepmc +1 more source